Cancer coalition aims to boost access to medicines in poorer countries




  • In US
  • 2022-05-20 06:13:43Z
  • By Reuters

By Jennifer Rigby

LONDON (Reuters) - Pharmaceutical companies including Novartis and Roche have teamed up with global cancer organisations in an alliance aimed at getting more oncology medications to poorer countries.

Currently, fewer than 50% of the cancer drugs on the World Health Organization's (WHO) essential medicines list are available in low and middle income countries, and the disease burden is growing. Without action, almost three in four cancer deaths are set to occur in these settings in the next decade.

In the first concrete step for the Access to Oncology Medicines (ATOM) Coalition, Novartis has licensed its blood cancer drug nilotinib to the United Nations' Medicines Patent Pool (MPP), allowing generic manufacturers to access the know-how to produce the drug at scale and at a lower cost.

Previously, the technology behind HIV drugs and COVID-19 has been shared in this way, but nilotinib is the first drug for a non-communicable disease in the pool, ATOM said.

It only has a year left on its patent, but Novartis' head of global health Lutz Hegemann said generic manufacturers had signalled it was still worthwhile.

"I think in a year there's a lot that you can try to test and this is not the only medicine that we would consider offering up," he said in an interview.

The aim of the coalition is not just to provide the drugs but also support training, diagnostics and delivery to get them to patients, the Union for International Cancer Control - a key partner - said.

The coalition begins with $32 million from the private sector and will focus initially on capacity building activities in ten lower and middle income countries, developing existing initiatives.

The Access to Medicine Foundation, which has long called out the inequality in access to drugs and care, will collaborate with the group.

"You've got some of the top minds ... the people with deep pockets, the shelves stocked with drugs .... We will be tracking progress on how this consortium delivers," said Jayasree Iyer, director of the foundation.

(Reporting by Jennifer Rigby; Editing by Mark Potter)

COMMENTS

More Related News

Global monkeypox outbreak isn
Global monkeypox outbreak isn't an international public health emergency 'at present,' WHO rules

Both the World Health Organization director-general and an emergency committee convened Thursday agree that monkeypox isn't a international public health...

WHO says over 900 probable cases of acute hepatitis reported in children
WHO says over 900 probable cases of acute hepatitis reported in children
  • US
  • 2022-06-24 21:50:58Z

The WHO said that the European Region accounted for half the probable cases, including 267 from the United Kingdom, while a third of the probable cases were ...

Chimerix gets up to $25.3 million contract from Canada for smallpox drug
Chimerix gets up to $25.3 million contract from Canada for smallpox drug
  • US
  • 2022-06-24 14:50:46Z

There have been more than 3,200 confirmed cases of monkeypox and one death reported in the last six weeks from 48 countries where it does not usually spread,...

Roche sceptical about investing more in
Roche sceptical about investing more in 'guided-missile' ADC cancer drugs
  • US
  • 2022-06-24 10:46:11Z

MANNHEIM (Reuters) -Roche remains sceptical about investing more in antibody-drug conjugates (ADCs), which have been described as "guided-missile" cancer...

GSK, Novartis pledge funds for diseases that mostly affect the poor
GSK, Novartis pledge funds for diseases that mostly affect the poor
  • US
  • 2022-06-23 10:32:04Z

LONDON (Reuters) -GSK and Novartis reinforced commitments on Thursday to tackle neglected tropical diseases, as world leaders and health experts gather in...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US